Scott Kelly

2018

In 2018, Scott Kelly earned a total compensation of $1.2M as Chief Medical Officer at Flexion Therapeutics.

Compensation breakdown

Bonus$128,000
Option Awards$482,189
Salary$400,000
Stock Awards$185,910
Other$12,558
Total$1,208,657

Kelly received $482.2K in option awards, accounting for 40% of the total pay in 2018.

Kelly also received $128K in bonus, $400K in salary, $185.9K in stock awards and $12.6K in other compensation.

Rankings

In 2018, Scott Kelly's compensation ranked 8,256th out of 14,244 executives tracked by ExecPay. In other words, Kelly earned more than 42.0% of executives.

ClassificationRankingPercentile
All
8,256
out of 14,244
42nd
Division
Manufacturing
3,266
out of 5,762
43rd
Major group
Chemicals And Allied Products
1,224
out of 2,125
42nd
Industry group
Drugs
1,024
out of 1,814
44th
Industry
Pharmaceutical Preparations
797
out of 1,388
43rd
Source: SEC filing on April 26, 2019.

Kelly's colleagues

We found four more compensation records of executives who worked with Scott Kelly at Flexion Therapeutics in 2018.

2018

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

2018

David Arkowitz

Flexion Therapeutics

Chief Financial Officer

2018

Neil Bodick

Flexion Therapeutics

Chief Scientific Officer

2018

Mark Levine

Flexion Therapeutics

General Counsel

News

You may also like